ArticleThe Journal of clinical investigation2025

Targeting legumain-mediated cell-cell interaction sensitizes glioblastoma to immunotherapy in preclinical models.

Lizhi Pang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.